A dramatic increase in the levels of SREBP-2 mRNA and protein was detected in CML-treated HK-2 cells (Figures 4(a) and 4(b)), and the SREBP-2 nuclear protein was elevated as well (Figure 4(c)). Here, SREBF2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.